News | May 14, 2026
Wegovy delivers consistent weight loss & heart benefits for women across menopause: Novo Nordisk study
Nearly one in five women worldwide are now living with obesity
Nearly one in five women worldwide are now living with obesity
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
The Hydrus Microstent stands out as the first and only MIGS device backed by five-year clinical outcomes
The iStent platform uses tiny surgical implants to lower eye pressure by restoring the eye’s natural fluid drainage system in patients with glaucoma
Especially valuable for young patients with multiple blocks & underlying conditions that may render angioplasty procedures with drug-eluting stents ineffective
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
.jpg)
Evonik's six innovation growth fields are: Sustainable nutrition, healthcare solutions, advanced food ingredients, membranes, cosmetic solutions, and additive manufacturing
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
It signals Cordis' renewed investment in innovation
First immunotherapy combination approved in the US for BCG-naïve high-risk NMIBC demonstrates a 32% reduction in the risk of disease recurrence, progression, or death
Subscribe To Our Newsletter & Stay Updated
